Antimutagenic effects of piperine on cyclophosphamideinduced chromosome aberrations in rat bone marrow cells

Asian Pacific Journal of Cancer Prevention

Volumn 8, Issue 4, 2007, Pages 623-627

  Wongpa, Sareeya ^a   Himakoun, Lakana ^a   Soontornchai, Sarisak ^b   Temcharoen, Punya ^a  

^a Mahidol University ^*  (Thailand)

^b SUKHOTHAI THAMMATHIRAT OPEN UNIVERSITY   (Thailand)

Author keywords

Antimutagenic effects; Chromosome aberrations; Cyclophosphamide; Piperine

Indexed keywords

1,3 BENZODIOXOLE DERIVATIVE; ALKALOID; ALKYLATING AGENT; AMIDE; ANTIMUTAGENIC AGENT; CYCLOPHOSPHAMIDE; PIPERIDINE DERIVATIVE; PIPERINE;

ANIMAL; ARTICLE; BLACK PEPPER; BONE MARROW; CELL CULTURE; CHEMISTRY; CHROMOSOME ABERRATION; DOSE RESPONSE; DRUG EFFECT; MALE; MITOSIS; MITOSIS INDEX; RAT; WISTAR RAT;

ALKALOIDS; ANIMALS; ANTIMUTAGENIC AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; BENZODIOXOLES; BONE MARROW; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MITOSIS; MITOTIC INDEX; PIPER NIGRUM; PIPERIDINES; POLYUNSATURATED ALKAMIDES; RATS; RATS, WISTAR;

EID: 58249088641     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Adler I D (1984). Cytogenic tests in mammals. Oxford IRL Press, pp. 275-306.
2. Adler I D, Ramarao G, Epstein S S (1971). In vivo cytogenic effects of trimethylphosphate and of tepa on bone marrow cells of male rats. Mutation Res, 13, 263-73.
3. Ali-Osman F (1989). Quenching of DNA cross-link precursors of chloroethylnitrosoureas and attenuation of DNA interstrand cross-linking by glutathione. Cancer Res, 49, 5258-61.
4. Ames B N (1983). Dietary carcinogens and anticarcinogens. Science, 221, 1256-64.
5. Atal C K, Dhar K L, Singh J (1975). The chemistry of the Indian piper species. Lloydia, 38, 256.
6. Atal C K, Dubey R K, Singh J (1985). Biochemical basis of enhanced drug bioavailability by piperine: Evidence that piperine is a potent inhibitor of drug metabolism. J Pharmacol Exp Therapeutics, 232, 258-62.
7. Azevedo L, Gomes J C, Stringheta P C, et al (2003). Black bean (Phaseolus vulgaris L.) as a protective agent against DNA damage in mice. Fd Chem Toxicol, 41, 1671-6.
8. Bajad S, Coumar M, Khajuria R, et al (2003). Characterization of a new rat urinary metabolite of piperine by LC/NMR/MS studies. Eur J Pharma Sci, 19, 413-21.
9. Bajad S, Singla AK, Bedi K L (2002). Liquid chromatographic method for determination of piperine in rat plasma: application to pharmacokinetics. J Chromatography B, 776, 245-9.
10. Baumann F, Preiss R (2001). Cyclophosphamide and related anticancer drugs. J Chromatography B, 764, 173-192.
11. Bhat B G, Chandrasekhara N (1986). Studies on the metabolism of piperine: absorption, tissue distribution and excretion of urinary conjugates in rats. Toxicology, 40, 83-92.
12. Bhat B G, Chandrasekhara N. (1987a). Interaction of piperine with rat liver microsomes. Toxicology, 44, 91-8.
13. Bhat B G, Chandrasekhara N (1987b). Metabolic disposition of piperine in the rat. Toxicology, 44, 99-106.
14. Brock N, Hohorst H J (1967). Metabolism of cyclophosphamide. Cancer, 20, 900-4.
15. Brusick D (1982). Principles and methods of toxicology. New York: Raven Press.
16. Brusick D (1987). Principles of Genetic Toxicology (2nd ed.). New York: Plenum Press.
17. Burk R F (1983). Glutathione dependent protection by rat liver microsomal protein against lipid peroxidation. Biochem Biophys Acta, 757, 21-8.
18. Capasso R, Izzo A A, Borrelli F, et al (2002). Effect of piperine, the active ingredient of black pepper, on the intestinal secretion in mice. Life Sci, 71, 2311-7.
19. Chopra RN, Chopra IC (1955). A review of work on Indian medicinal plants. Indian council of medical research, special report series no.3, New Delhi, India.
20. Colvin M, Hilton J (1988). Cellular resistance to cyclophosphamide. In P.V. Woolley and K.D. Tew (Eds.), Mechanisms of drug resistance in neoplastic cells (pp. 161-171). New York: Academic Press.
21. Colvin M, Padgett C A, Fenselau C (1973). A biologically active metabolite of cyclophosphamide. Cancer Res, 33, 915-8.
22. Dalvi R R, Dalvi PS (1991). Comparison of the effects of piperine administered intragastrically and intraperitoneally on the liver and liver mixed-function oxidases in rats. Drug Metab Drug Interact, 9, 23-30.
23. Dhuley J N, Raman PH, Mujumdar M, et al (1993). Inhibition of lipid peroxidation by piperine during experimental inflammation in rats. Indian J Exp Biol, 31, 443-5.
24. Dreosti I E (1998). Nutrition, cancer, and aging. Ann NY Acad Sci, 854, 371-7.
25. Flora, S.D. (1998). Mechanism of inhibitors of mutagenensis and carcinogenesis. Mutation Research, 402, 151-8. Friedman O M, Myles A, Colvin M (1979).
26. Friedman O M, Myles A, Colvin M (1979). Cyclophosphamide and related phosphamide mustards. Adv Cancer Chemother, 1, 143-204.
27. Govindarajan, V.S. (1977). Pepper-chemistry, technology and quality evaluation. CRC Crit Rev Food Sci Nutr, 9, 115-250.
28. Heddle J A (1973). A rapid in vivo test for chromosomal damage. Mutation Research, 18, 187-90.
29. Heddle J A. (1982). Mutagenicity New Horizons in Genetic Toxicology (1st ed.). Academic Press. Heddle J A, Moody J A, Thompson LU, et al (1999).
30. New approaches to antimutagenesis. J Env Path Tox Oncol, 18, 95-101.
31. IARC (1981). Some Antineoplastic and Immunosuppressive agents, IARC Monographs, Vol. 26, International Agency for Research on Cancer, Lyon, pp.165-120.
32. Ito Y, Ito M (2001). Suppressive effect of (-)-Epigallocatechin gallate on aflatoxin B1-induced chromosome aberrations in rat bone marrow cells. J Hlth Sci, 47, 248-57.
33. Kaplowitz N (1980). Physiologic significance of the glutathione- S-transferase. Am J Physiol, 239, 439-44.
34. Khajuria A, Thusu N, Zutshi U, et al (1998). Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa. Molec Cell Biochem, 189, 113-8.
35. Koul S, Koul JL, Taneja S C, et al (2000). Structure-activity relationship of piperine and its synthetic analogues for their inhibitory potentials of rat hepatic microsomal constitutive and inducible cytochrome P450 activities. BioorgMed Chem, 8, 251-68.
36. Lang T, Klein K, Fischer J, et al (2001). Extensive genetic polymorphism in the human liver. Pharmacogenetics, 11, 399-415.
37. Lewis Y S (1977). Important spices from Southeast Asia: Their cultivation and technology. In: 3rd Asian symposium on medicinal plants and spices, Columbo, pp. 139-51.
38. Piyachaturawat P, Glinsukon T, Toskulkao C (1983). Acute and subacute toxicity of piperine in mice, rats and hamsters. Toxicol Letters, 16, 351-9.
39. Platel K, Srinivasan K (2004). Digestive stimulant action of spices: A myth or reality. Indian J Med Res, 119, 167-79.
40. Povirk LF, Shuker D E (1994). DNA damage and mutagenesis induced by nitrogen mustards. Mutation Res, 318, 205-26.
41. Preston R J, Dean B J, Galloway S, et al(1987). Mammalian in vivo cytogenic assays analysis of chromosome aberration in bone marrow cells. Mutation Res, 189, 157-65.
42. Reen R K, Roesch S F, Kiefer F, et al (1996). Piperine impairs cytochrome P4501A1 activity by direct interaction with the enzyme and not by down regulation of CYP1A1 gene expression in the rat hepatoma 5L cell line. Biochem Biophys Research Communications, 218, 562-9.
43. Reen R K, Wiebel F J, Singh J (1997). Piperine inhibits aflatoxin B1-induced cytotoxicity and genotoxicity in V79 Chinese hamster cells genetically engineered to express rat cytochrome P4502B1. J Ethnopharmacol, 58, 165-73.
44. Selvendiran K, Banu S M, Sakthisekaran D (2004). Protective effect of piperine on benzo(a)pyrene-induced lung carcinogenesis in Swiss albino mice. Clinica Chimica Acta, 350, 73-8.
45. Selvendiran K, Padmavathi R, Magesh V, et al (2005). Preliminary study on inhibition of genotoxicity by piperine in mice. Fitoterapia, 76, 296-300.
46. Selvendiran K, Singh J P V, Krishnan K B, et al(2003). Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia, 74, 109-15.
47. Sharma N, Trikha P, Athar M et al(2001). Inhibition of benzo(a)pyrene-and cyclophosphamide-induced mutagenicity by Cinnamomum cassia. Mutation Res, 480-481, 179-88.
48. Shimada T, Yamazaki H, Mimura M, et al (1994). Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J Pharmacol Exp Ther, 270, 414-23.
49. Shukla Y, Arora A, Taneja P (2002). Antimutagenic potential of curcumin on chromosomal aberrations in Wistar rats. Mutation Res, 515, 197-202.
50. Shukla Y, Taneja P (2002). Antimutagenic effects of garlic extract on chromosomal aberrations. Cancer Letters, 176, 31-6.
51. Singh J, Dubey R K, Atal C K (1986). Piperine-mediated inhibition of glucuronidation activity in isolated epithelial cells of the guinea pig small intestine: Evidence that piperine lowers the endogenous UDP-glucuronic acid content. J Pharmacol Exp Therapeutics, 236(2), 488-93.
52. Singh R P, Sharad S, Kapur S (2004). Free radicals and oxidative stress in neurodegenerative diseases: relevance of dietary antioxidants. JIACM, 5, 218-25.
53. Surh Y-J, Lee E, Lee L M (1998). Chemoprotective properties of some pungent ingredients present in red pepper and ginger. Mutation Res, 402, 259-67.
54. Vainio H, Magee PN, Mc-Gregor DB, et al (1992). Mechanisms of carcinogenesis in risk identification. WHO-IARC Scientific Publications, No. 16.
55. Voskoboinik I, Drew R, Ahokas JT (1997). Peroxisome proliferator nafenopin potentiated cytotoxicity and genotoxicity of cyclophosphamide in the liver and bone marrow cells. Chem-Biol Interact, 105, 81-97.
56. World Health Organization (WHO). Environmental health criteria 51. (1985). Guide to short-term tests for detecting mutagenic and carcinogenic chemicals.